EUVIMEDEUVIMED entdecken
Crossref

FDA Modernization Act 2.0 allows for alternatives to animal testing

Jason J Han

Artificial Organs · 2023-03 · 47 (3) · 449-450

DOI: 10.1111/aor.14503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Artificial Organs, online erschienen am 10.02.2023. Verfasst von Jason J Han. Hauptthemen laut MEDLINE: Animal Testing Alternatives. Die Arbeit wurde bisher 396-mal zitiert (Crossref) und nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

On December 29, 2022, President Biden signed into law the FDA Modernization Act 2.0. The bill essentially refutes the Federal Food, Drug, and Cosmetics Act of 1938, which mandated animal testing for every new drug development protocol. While for the past century, the mandate was intended to ensure certain quality and safety standards for drugs and medical devices, recent advancements in science have begun to offer increasingly viable alternatives to animal testing. For certain areas such as organ replacement therapies, non‐animal testing may not prove to be an adequate alternative in the foreseeable future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Animal Testing AlternativesAnimalsUnited StatesUnited States Food and Drug Administration

Zitieren

APA

Han, J. J. (2023). FDA Modernization Act 2.0 allows for alternatives to animal testing. Artificial Organs, 47(3), 449-450. https://doi.org/10.1111/aor.14503

Vancouver

Han JJ. FDA Modernization Act 2.0 allows for alternatives to animal testing. Artificial Organs. 2023;47(3):449-450. doi:10.1111/aor.14503

BibTeX
@article{Han2023,
  author = {Han, Jason J},
  title = {FDA Modernization Act 2.0 allows for alternatives to animal testing},
  journal = {Artificial Organs},
  year = {2023},
  volume = {47},
  number = {3},
  pages = {449--450},
  doi = {10.1111/aor.14503}
}
Kostenlos starten →